Rubella screening: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There | There are no standard screening test recommended for rubella infection, however pregnant women with suspected rubella infection must be investigated to confirm the diagnosis to prevent fetal anomalies. | ||
==Screening== | ==Screening== | ||
There is no screening test for rubella, however, if there is a high clinical suspicion of rubella infection during pregnancy, serum IgG and IgM antibodies against rubella may be ordered. Also, if a pregnant woman proves to be not immune aganist rubella, vaccination with MMR should be deferred till after delivery due to the theoretical teratogenic effects of the rubella vaccine.<ref name="USPSTF">U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.</ref><ref name="CDC"> Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.</ref><ref name="pmid28370103">{{cite journal| author=Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P| title=Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis. | journal=J Med Virol | year= 2017 | volume= | issue= | pages= | pmid=28370103 | doi=10.1002/jmv.24818 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28370103 }} </ref> | There is no screening test for rubella, however, if there is a high clinical suspicion of rubella infection during pregnancy, serum IgG and IgM antibodies against rubella may be ordered. Also, if a pregnant woman proves to be not immune aganist rubella, vaccination with MMR should be deferred till after delivery due to the theoretical teratogenic effects of the rubella vaccine.<ref name="USPSTF">U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.</ref><ref name="CDC"> Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.</ref><ref name="pmid28370103">{{cite journal| author=Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P| title=Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis. | journal=J Med Virol | year= 2017 | volume= | issue= | pages= | pmid=28370103 | doi=10.1002/jmv.24818 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28370103 }} </ref> | ||
Revision as of 14:58, 27 April 2017
|
Rubella Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rubella screening On the Web |
|
American Roentgen Ray Society Images of Rubella screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.
Overview
There are no standard screening test recommended for rubella infection, however pregnant women with suspected rubella infection must be investigated to confirm the diagnosis to prevent fetal anomalies.
Screening
There is no screening test for rubella, however, if there is a high clinical suspicion of rubella infection during pregnancy, serum IgG and IgM antibodies against rubella may be ordered. Also, if a pregnant woman proves to be not immune aganist rubella, vaccination with MMR should be deferred till after delivery due to the theoretical teratogenic effects of the rubella vaccine.[1][2][3]
References
- ↑ U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.
- ↑ Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.
- ↑ Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P (2017). "Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis". J Med Virol. doi:10.1002/jmv.24818. PMID 28370103.